Evidence map›Paper›PMID 39754221›Full record

ArticleBreast cancer research : BCR2025

Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models.

Sarmila Majumder, Sanjay Mishra, Neelam Shinde, Maria C Cuitino, Morgan Bauer, Dinesh Ahirwar, Mustafa M Basree, Vijaya Bharti, Kate Ormiston, Resham Mawalkar and 6 more

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sarmila Majumder *Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. sarmila.majumder@osumc.edu.
Sanjay Mishra *Department of Pathology, The Ohio State University, Columbus, OH, 43210, USA.
Neelam Shinde *Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Maria C CuitinoDepartment of Radiation Oncology, The Ohio State University, Columbus, OH, USA.
Morgan BauerDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Dinesh AhirwarDepartment of Pathology, The Ohio State University, Columbus, OH, 43210, USA.
Mustafa M BasreeDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Vijaya BhartiDepartment of Pathology, The Ohio State University, Columbus, OH, 43210, USA.
Kate OrmistonDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Resham MawalkarDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Sara AlsammeraiDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Gautam SarathyDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Anna E VilgelmDepartment of Pathology, The Ohio State University, Columbus, OH, 43210, USA.
Xiaoli ZhangDepartment of Biomedical Informatics and Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
Ramesh K GanjuDepartment of Pathology, The Ohio State University, Columbus, OH, 43210, USA.
Bhuvaneswari RamaswamyDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Bhuvaneswari.ramaswamy@osumc.edu.

Funding

Combining senescence-inducing and senolytic agents to improve melanoma therapyR37CA233770 · NCI · VANDERBILT UNIVERSITY · PI VILGELM, ANNA E · 2019 to 2025
$2.4M
Unravel the novel role of S100A7 and its functional partners in Metastatic Triple Negative Breast Cancer Racial DisparityR01CA292020 · NCI · OHIO STATE UNIVERSITY · PI Ramesh K. Ganju · 2024 to 2026
$2.3M
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancerR01CA231857 · NCI · OHIO STATE UNIVERSITY · PI GANJU, RAMESH K., STOVER, DANIEL G. · 2019 to 2023
$2.2M
NCI NIH HHS R01 CA231857NCI NIH HHS R01 CA292020NCI NIH HHS R37 CA233770NIH HHS CA231857
6 · The paper itself

Abstract

backgroundEpidemiological studies associate an increase in breast cancer risk, particularly triple-negative breast cancer (TNBC), with lack of breastfeeding. This is more prevalent in African American women, with significantly lower rate of breastfeeding compared to Caucasian women. Prolonged breastfeeding leads to gradual involution (GI), whereas short-term or lack of breastfeeding leads to abrupt involution (AI) of the breast. Our previous study utilizing a murine model demonstrated precancerous changes, specifically hyperplasia, a non-obligate precursor of breast cancer in the mammary glands of AI mice. Here we investigated mechanisms during early events of AI that prompts precancerous changes in mouse mammary glands.

methodsUniparous FVB/N mice were randomized to AI and GI on postpartum day 7 when all pups were removed from AI dams. GI dams were allowed to nurse the pups till day 31. Cell death kinetics and gene expression were assessed by TUNEL assay and qPCR respectively. Immune cell changes were investigated by flow cytometry, cytokine array and multiplex immunofluorescence. 3D-organoid cultures were used for in vitro assay of luminal progenitor cells.

resultsAI results in rapid cell death, DNA repair response, and immunosuppressive myeloid cells infiltration, leading to a chronically inflamed microenvironment. GI elicits a more controlled immune response and extended cell death. At the peak of cell death, AI glands harbored more immunosuppressive myeloid-derived suppressor cells (MDSCs) and CD206 + M2-like macrophages, known to promote oncogenic events, compared to GI glands. AI glands exhibit an enrichment of CCL9-producing MDSCs and CD206 + M2-like macrophages that promote expansion of ELF5 + /ERα- luminal cells, both in vitro and in vivo. Multiplex imaging of AI glands demonstrated an increase in ELF5 + /WNT5a + luminal cells alongside a reduction in the ELF5 + /ERα + population when involution appeared histologically complete. A significantly higher number of CD206 + cells in post involution AI gland attests to a chronically inflamed state induced by AI.

conclusionsOur findings reveal significant disparities between AI and GI gland dynamics at the early phase of involution. CCL9, secreted by immune cells at the peak of cell death promotes expansion of Elf5 + /ERα- luminal progenitor cells, the putative precursors of TNBC connecting early events of AI with increased breast cancer risk.

Indexed as

Disease Models, AnimalMammary Glands, AnimalAnimalsFemaleHumansLactationMacrophagesMicePrecancerous ConditionsTriple Negative Breast NeoplasmsAbrupt involutionBreast cancerBreastfeedingCCL9M2-like macrophages

Identifiers

PMID39754221
PMCPMC11697808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.